Literature DB >> 27001588

Antiangiogenic Therapy for Glioblastoma: Complex Biology and Complicated Results.

Mark R Gilbert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27001588     DOI： 10.1200/JCO.2016.66.5364

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  p53 Mutation: Critical Mediator of Therapy Resistance against Tumor Microenvironment.

Authors:  Ali S Arbab; Meenu Jain; B R Achyut
Journal:  Biochem Physiol       Date:  2016-10-28

Review 2.  Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.

Authors:  Brittany C Parker Kerrigan; Yuzaburo Shimizu; Michael Andreeff; Frederick F Lang
Journal:  Cytotherapy       Date:  2017-02-21       Impact factor: 5.414

3.  Quantile Function on Scalar Regression Analysis for Distributional Data.

Authors:  Hojin Yang; Veerabhadran Baladandayuthapani; Arvind U K Rao; Jeffrey S Morris
Journal:  J Am Stat Assoc       Date:  2019-06-21       Impact factor: 5.033

Review 4.  Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.

Authors:  Hui K Gan; Martin van den Bent; Andrew B Lassman; David A Reardon; Andrew M Scott
Journal:  Nat Rev Clin Oncol       Date:  2017-07-04       Impact factor: 66.675

Review 5.  Radioimmunotherapy (RIT) in Brain Tumors.

Authors:  Ali Gholamrezanezhad; Hossein Shooli; Narges Jokar; Reza Nemati; Majid Assadi
Journal:  Nucl Med Mol Imaging       Date:  2019-11-12

Review 6.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

7.  Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.

Authors:  Siti Aminah Abdul Rahim; Anne Dirkse; Anais Oudin; Anne Schuster; Jill Bohler; Vanessa Barthelemy; Arnaud Muller; Laurent Vallar; Bassam Janji; Anna Golebiewska; Simone P Niclou
Journal:  Br J Cancer       Date:  2017-08-10       Impact factor: 7.640

8.  Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model.

Authors:  Yi Li; Jun Li; Yat Ming Woo; Zan Shen; Hong Yao; Yijun Cai; Marie Chia-Mi Lin; Wai Sang Poon
Journal:  BMC Cancer       Date:  2017-02-13       Impact factor: 4.430

9.  CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.

Authors:  C Zhu; I Chrifi; D Mustafa; M van der Weiden; P J M Leenen; D J Duncker; J M Kros; C Cheng
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

10.  Transcription Factor NFAT5 Promotes Glioblastoma Cell-driven Angiogenesis via SBF2-AS1/miR-338-3p-Mediated EGFL7 Expression Change.

Authors:  Hai Yu; Jian Zheng; Xiaobai Liu; Yixue Xue; Shuyuan Shen; Lini Zhao; Zhen Li; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2017-09-21       Impact factor: 5.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.